343 related articles for article (PubMed ID: 7958535)
1. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ
Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
[TBL] [Abstract][Full Text] [Related]
2. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.
Cameron NE; Cotter MA; Hohman TC
Diabetologia; 1996 Feb; 39(2):172-82. PubMed ID: 8635669
[TBL] [Abstract][Full Text] [Related]
3. Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats.
Cameron NE; Cotter MA; Dines KC; Hohman TC
J Diabetes Complications; 1996; 10(1):43-53. PubMed ID: 8639974
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats.
Cotter MA; Mirrlees DJ; Cameron NE
Eur J Pharmacol; 2001 Apr; 417(3):223-30. PubMed ID: 11334854
[TBL] [Abstract][Full Text] [Related]
5. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Archibald V; Dines KC; Maxfield EK
Diabetologia; 1994 May; 37(5):449-59. PubMed ID: 8056181
[TBL] [Abstract][Full Text] [Related]
6. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
Cotter MA; Cameron NE; Hohman TC
J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
8. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
[TBL] [Abstract][Full Text] [Related]
9. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
Cameron NE; Cotter MA; Robertson S
Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
[TBL] [Abstract][Full Text] [Related]
10. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Mayer JH; Tomlinson DR
Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
Maxfield EK; Cameron NE; Cotter MA; Dines KC
Diabetologia; 1993 Dec; 36(12):1230-7. PubMed ID: 8307249
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
13. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
[TBL] [Abstract][Full Text] [Related]
14. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
15. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase.
Tomlinson DR; Dewhurst M; Stevens EJ; Omawari N; Carrington AL; Vo PA
Diabet Med; 1998 Jul; 15(7):579-85. PubMed ID: 9686698
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve.
Calcutt NA; Mizisin AP; Kalichman MW
Eur J Pharmacol; 1994 Jan; 251(1):27-33. PubMed ID: 8137868
[TBL] [Abstract][Full Text] [Related]
17. Dissociation between biochemical and functional effects of the aldose reductase inhibitor, ponalrestat, on peripheral nerve in diabetic rats.
Cameron NE; Cotter MA
Br J Pharmacol; 1992 Dec; 107(4):939-44. PubMed ID: 1467842
[TBL] [Abstract][Full Text] [Related]
18. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
19. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC
J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071
[TBL] [Abstract][Full Text] [Related]
20. Increased resistance to hypoxic conduction block in sciatic nerves of diabetic rats: effects of extracellular glucose concentration and of aldose reductase inhibition.
Carrington AL; Ettlinger CB; Tomlinson DR
J Diabetes Complications; 1994; 8(1):33-9. PubMed ID: 8167385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
